We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iofina Plc | LSE:IOF | London | Ordinary Share | GB00B2QL5C79 | ORD 1P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
20.00 | 21.00 | 20.50 | 19.50 | 19.50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | USD 42.2M | USD 7.87M | USD 0.0410 | 5.00 | 39.33M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:28:03 | O | 13 | 20.65 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
16/4/2024 | 13:11 | ALNC | Iofina reduces 2024 profit prediction amid high fees in first quarter |
16/4/2024 | 07:00 | UK RNS | Iofina PLC Q1 2024 Corporate Update |
17/1/2024 | 07:00 | UKREG | Iofina PLC Holding(s) in Company |
15/1/2024 | 12:00 | ALNC | Iofina shares fall despite increased production and sunny outlook |
15/1/2024 | 07:00 | UKREG | Iofina PLC Q4 2023 Corporate Update |
30/11/2023 | 14:25 | ALNC | TRADING UPDATES: SkinBio launches food supplement on Amazon |
30/11/2023 | 07:00 | UKREG | Iofina PLC IO#9 Update |
20/10/2023 | 09:11 | ALNC | Iofina inks deal with new partner for latest iodine plant in Oklahoma |
20/10/2023 | 07:04 | UKREG | Iofina PLC Signed Agreement for IO#10 and Q3 2023 Update |
11/9/2023 | 10:06 | ALNC | Iofina hails high iodine prices and strong demand as profit surges |
Iofina (IOF) Share Charts1 Year Iofina Chart |
|
1 Month Iofina Chart |
Intraday Iofina Chart |
Date | Time | Title | Posts |
---|---|---|---|
19/4/2024 | 18:38 | Iofina - US Iodine producer | 8,777 |
11/4/2024 | 10:02 | Iofina | 4 |
11/4/2024 | 09:54 | iofina iodine and Canabis oil | 11,165 |
15/5/2023 | 16:17 | Iofina | 44,906 |
24/2/2023 | 11:48 | Iofina recovery | 7,066 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2024-04-19 15:28:03 | 20.65 | 13 | 2.68 | O |
2024-04-19 15:24:32 | 20.65 | 13 | 2.68 | O |
2024-04-19 15:22:53 | 20.65 | 123 | 25.40 | O |
2024-04-19 15:20:21 | 20.50 | 103,170 | 21,149.85 | O |
2024-04-19 15:19:20 | 20.41 | 5,000 | 1,020.50 | O |
Top Posts |
---|
Posted at 19/4/2024 09:20 by Iofina Daily Update Iofina Plc is listed in the Offices-holdng Companies,nec sector of the London Stock Exchange with ticker IOF. The last closing price for Iofina was 19.50p.Iofina currently has 191,858,408 shares in issue. The market capitalisation of Iofina is £39,330,974. Iofina has a price to earnings ratio (PE ratio) of 5.00. This morning IOF shares opened at 19.50p |
Posted at 17/4/2024 13:03 by gb904150 This one I think you mean?Stocko says FY23 results out next Tuesday 23rd April. Regarding the brine supply contracts - Tom explains that while that agreement was in the supplier's favour at the start of the contract, it was in IOF's favour towards the end of it. The new contract is at a new market rate that is obviously now more beneficial for the supplier and will cost IOF a bit of profit in the short term, but over the course of the contract will probably even out. Perhaps IOF recognise that one of the reasons brine supply has been poor is because this contract no longer works well for the supplier. They figure a win-win is agreeing to a new contract which offers a higher brine price (but lower margins to IOF) but will result in higher brine supply. As ever, they are very conservative in their forecasts, but FY 2023 results I think will give us a much fuller picture. I know this company is hated by many investors, but fwics they are making slow but steady progress.....and are cheaply rated as such. Now if only they could start paying a divi and show they are investor friendly.... |
Posted at 11/4/2024 15:09 by severnof9 I share the same outlook as Chillpill in respect of quarter 1 and overall trading.The price per Kg of Iodine is favourable and the latest company updates are pointing toward a positive future for iodine production in my view. I particularly like these extracts from the Q4 Corporate update hxxps://iofina.com/q "Demand for the Company’s crystalline iodine remained robust during the final quarter, whilst sales of iodine derivatives had mixed results. Regarding non-iodine products, sales of a key product mainly used in the semiconductor industry improved significantly in the second half of the year after a slower-than-anticipa "In terms of new products, Iofina Chemical will be adding to its iodine derivatives product range in H1 2024, including an existing product in the market for which there is strong demand. The Company also expects to increase sales of its crystalline iodine to customers in Europe in 2024 through existing and new relationships." I read somewhere this week that IOF iodine sales to Europe make up 1% of iodine sales by geography with the vast majority going to the US and Asia. If sales can be generated in Europe that should help with turnover from increased iodine production. I have steadily purchased shares this week using up my 2024 ISA allowance on this unexplained dip so hoping for good news to come. Chillpill I know you state you have taken a recent deep dive into IOf regarding delays in the roll out of sites and I also note the reference to IO9 not being reliant of SWD due to its design. Any insight you can share on these comments would be appreciated. Many thnaks |
Posted at 10/4/2024 14:40 by gb904150 Isn't this all a bit premature?Last year on 12th April we had a Q1 production update. 2 weeks after that we should have our 2023 full year results for YE 31/12/2023. That will show what our finances look like with 12 months of relatively strong iodine prices, little to no debt (so no financing costs) and hopefully stable production. Only then can we see if the recent 40% drop in the share price, seemingly on no major changes is justified or not. TBH at this stage it would need to be an absolutely abysmal operational performance for that drop to be justified. Yes, I know everyone hates the management and those shouts are even louder atm because the share price is so weak....but can we hold on and then roast them based on some actual results first please? |
Posted at 04/4/2024 18:00 by naphar Wouldn’t buybacks have just helped sellers sell at a higher price to the cost of the company?What stops a share price falling back anyway when the buyback pot runs out? And where did they ever say they set aside a million to buy back from the market? Their intent for a buy back from my recollection, as I stated many times, was to buy a block being sold as below market value. Clearly what they are doing currently isn’t working from a share price perspective, for whatever reason. And I wish it were. And I do t even mind the idea of a buyback at the right price, it should be earnings accretive. As long as they have the cash for expansion and to fulfill other opportunities, both of which seem too slow in coming to fruition currently. |
Posted at 03/4/2024 10:27 by beeezzz Market is weak at the moment, as a PI you are irrelevant, which they have demonstrated over the years...Serraria - One thing you should understand, those running company are academics and not business men, if they were they would issued 10m share when share price was £2 and cleared all their debts, instead of waiting until share price was a few pence, which meant issuing substantially more shares creating greater dilution. |
Posted at 15/3/2024 08:12 by beercapafn What is going on. ?Something is wrong !!! We hope the money is piling up, but. Lack of news, transparently and openly promised at EVERY AGM, is just not happening. Lack of information, news, and forward plans. Good or bad. This has led to a collapse in the share price and market cap of 36% 192 million shares in issue X 36P = 69 million 192 million shares in issue X 23p = 44 million That's a drop of 25 million. Back at the AGM Tom stated that they had set aside 1 million for buybacks, to protect the share price from some small sellers affecting the share price. The BOD, for some reason (I suspect they have some aspirations of M&A ), has presided over a huge drop of 25 million in the value of IOF in any such venture. They have proved that they are incapable of finding new Brine at a rate to use capital accruing. So, I agree that a change in the business model needs to change. But I don't believe the current BOD have the skill set or breadth of experience to convince the market of that. And most definitely not with ANY involvement of Lance. Bit of a rant, but very frustrated at the lack of information and drop in Share Price |
Posted at 13/1/2024 12:31 by activmojo 55.0% potential upside indicated by Canaccord GenuityCanaccord Genuity set a target price of 40 GBX for the company, which when compared to the Iofina plc share price of 26 GBX at opening today (12/01/2024) indicates a potential upside of 55.0%. Trading has ranged between 22 (52 week low) and 38 (52 week high) with an average of 182,184 shares exchanging hands daily. The market capitalisation at the time of writing is £47,836,625. Iofina plc is a United Kingdom-based holding company. The Company is a specialist in the exploration and production of iodine and a manufacturer of specialty chemical products. The Company’s principal business is to identify, develop, build, own, and operate iodine extraction plants, focused on North America, based on the Company’s Wellhead Extraction Technology (WET) IOsorb technology. The Company, through its subsidiary, Iofina Resources, Inc., develops, builds, owns, and operates iodine extraction plants using its WET IOsorb technology. The Company, through its subsidiary, Iofina Chemical, Inc., manufactures halogen specialty chemicals derived from raw iodine, as well as non-iodine-based products. Its subsidiary, IofinaEX, Inc., is engaged in the extraction of cannabinoid-based products from hemp. The Company’s production operations are located in the United States, specifically in Kentucky and Oklahoma. Its other subsidiary is Iofina Resources, LLC. |
Posted at 03/11/2023 17:45 by serratia beeezzz, I might not have explained my thinking clearly.Each half year the share price moves in a range. I just compare that range to my version of OCF. Based on the last H1 figure the minimum ratio from historic figures implies a minimum share price of 21.5p. You could say in relation to H1 OCF it's never been cheaper.The upper limit is not constant. In 2020 it peaked at 15* OCF in 2021 8.5* and 2022 5*. A 42p share price would be 8* H1 OCF, not unreasonable. In addition H2 should be an improvement on H1 as the iodine price is holding and output increasing dropping the 8* figure. The broker figure of 42p (?) is at the higher end based on H1 but believable based on H2 estimates. I only use these figures as a rough guide as there are many macro figures that impact on share prices and sentiment such as wars/ recessions etc. A fair share price is not what I think it should be but what others think. |
Posted at 26/9/2023 10:22 by beercapafn Barry:believe that the BOD aren't concerned about the share price, they don't need to raise funds so the share price doesn't matter to them. But it does matter, anyone looking to take the company over would be encouraged by low SP, and likewise deterred by higher share price Having a higher market cap just adds security to Iofina's look in the world of chemicals and security on any future Browings. A more attractive investment proposition. Investors buying into a rising Market Cap and SP, not witnessing a steady decline. That is my view, against just having it sit on the balance sheet. |
Posted at 16/9/2023 23:24 by dk37 From tomorrow’s Sunday’s Daily MailOklahoma is one of the biggest oil and gas states in America, producing almost 500,000 barrels of crude a day and huge quantities of natural gas. Employing 15 per cent of Oklahoma’s workforce, the sector contributes $60billion (£48billion) a year to economic growth. Production is well honed, generating not just fossil fuels but vast amounts of oilfield brine. Progressive: Iofina has pioneered a way to extract iodine from the brine, turning dirty water into a valuable resource Progressive: Iofina has pioneered a way to extract iodine from the brine, turning dirty water into a valuable resource Traditionally, this has been viewed as waste water. AIM-listed Iofina considers it an asset. The firm has pioneered a way to extract iodine from the brine, turning dirty water into a valuable resource. Iodine has numerous applications. An essential mineral that promotes growth and brain health, it is added to salt and other food across the world. Iodine is also used to make images clearer in magnetic resonance imagery (MRI) scans and is a critical element of products from pesticides to preservatives. Iofina sells both pure iodine and related compounds used by manufacturers and industrial firms in the US and internationally. Midas recommended the shares in September last ear, when they were 23.5p and boss Tom Becker was about to start work on his sixth iodine plant in Oklahoma. That site is now up and running, with a seventh expected to come on stream next year. Assessing which locations will yield the most iodine and developing partnerships with oil and gas firms in those places takes time and effort. But Becker and his team are experienced and well connected, they know where to look for deals and plan to continue doing so. Recent hard work is paying off. Shares have risen 23 per cent to 29p over the past 12 months and Becker last week unveiled upbeat interim results, with pre-tax profit soaring 80 per cent to $4.7million (£3.8million), despite rising costs. Annual production is set to hit nearly 600 tons, with Becker optimistic of reaching 1,000 tons a year by 2027 at the latest. Iofina’s compound arm is firing on all cylinders, increasing sales and working with customers in sectors as diverse as animal feed and lithium batteries. Brokers expect strong, sustained growth across the group, suggesting the share price should reach 40p, as production increases and new deals come to fruition Midas verdict: Iofina shares have performed well but they should continue to rise, as Becker delivers his strategy. Iodine is in demand and Iofina’s technology is cleaner and lower-cost than many rivals. At 29p, the shares remain attractive. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions